BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23473835)

  • 1. Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression.
    Hulse KE; Norton JE; Suh L; Zhong Q; Mahdavinia M; Simon P; Kern RC; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Harris KE; Carter RG; Kato A; Schleimer RP
    J Allergy Clin Immunol; 2013 Apr; 131(4):1075-83, 1083.e1-7. PubMed ID: 23473835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of immunoglobulin D is increased in chronic rhinosinusitis.
    Sokoya M; Ramakrishnan VR; Frank DN; Rahkola J; Getz A; Kingdom TT; Kofonow JM; Nguyen Q; Janoff EN
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):317-323.e1. PubMed ID: 28958373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of IL-17 and syndecan-1 in nasal polyps and their correlation with nasal polyps.
    Gong GQ; Ren FF; Wang YJ; Wan L; Chen S; Yuan J; Yang CM; Liu BH; Kong WJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):412-418. PubMed ID: 28585128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.
    Takabayashi T; Kato A; Peters AT; Suh LA; Carter R; Norton J; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Fujieda S; Schleimer RP
    J Allergy Clin Immunol; 2012 Aug; 130(2):410-20.e5. PubMed ID: 22534535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps.
    Imoto Y; Kato A; Takabayashi T; Stevens W; Norton JE; Suh LA; Carter RG; Weibman AR; Hulse KE; Harris KE; Peters AT; Grammer LC; Tan BK; Welch K; Shintani-Smith S; Conley DB; Kern RC; Fujieda S; Schleimer RP
    J Allergy Clin Immunol; 2019 Dec; 144(6):1566-1574.e6. PubMed ID: 31562871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis.
    Min JY; Nayak JV; Hulse KE; Stevens WW; Raju PA; Huang JH; Suh LA; Van Roey GA; Norton JE; Carter RG; Price CPE; Weibman AR; Rashan AR; Ghosn EE; Patel ZM; Homma T; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Kato A; Hwang PH; Kern RC; Herzenberg LA; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Dec; 140(6):1562-1571.e5. PubMed ID: 28625807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Poposki JA; Uzzaman A; Nagarkar DR; Chustz RT; Peters AT; Suh LA; Carter R; Norton J; Harris KE; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
    J Allergy Clin Immunol; 2011 Jul; 128(1):73-81.e4. PubMed ID: 21497884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial genes in chronic rhinosinusitis with and without nasal polyps.
    Richer SL; Truong-Tran AQ; Conley DB; Carter R; Vermylen D; Grammer LC; Peters AT; Chandra RK; Harris KE; Kern RC; Schleimer RP
    Am J Rhinol; 2008; 22(3):228-34. PubMed ID: 18588753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.
    Van Roey GA; Vanison CC; Wu J; Huang JH; Suh LA; Carter RG; Norton JE; Shintani-Smith S; Conley DB; Welch KC; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Stevens WW; Kern RC; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Jul; 140(1):89-100.e2. PubMed ID: 27979430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular comparison of sinus mucosa vs polyp tissue from a single sinus cavity in chronic rhinosinusitis.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Int Forum Allergy Rhinol; 2015 Jan; 5(1):14-27. PubMed ID: 25332132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
    Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.
    Peterson S; Poposki JA; Nagarkar DR; Chustz RT; Peters AT; Suh LA; Carter R; Norton J; Harris KE; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
    J Allergy Clin Immunol; 2012 Jan; 129(1):119-27.e1-9. PubMed ID: 21943944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
    Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic airway inflammation provides a unique environment for B cell activation and antibody production.
    Feldman S; Kasjanski R; Poposki J; Hernandez D; Chen JN; Norton JE; Suh L; Carter RG; Stevens WW; Peters AT; Kern RC; Conley DB; Tan BK; Shintani-Smith S; Welch KC; Grammer LC; Harris KE; Kato A; Schleimer RP; Hulse KE
    Clin Exp Allergy; 2017 Apr; 47(4):457-466. PubMed ID: 28000955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgD-activated mast cells induce IgE synthesis in B cells in nasal polyps.
    Zhai GT; Wang H; Li JX; Cao PP; Jiang WX; Song J; Yao Y; Wang ZC; Wang ZZ; Wang MC; Liao B; Feng QM; Lu X; Wang H; Gao P; Liu Z
    J Allergy Clin Immunol; 2018 Nov; 142(5):1489-1499.e23. PubMed ID: 30102935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps.
    Hwang JW; Lee KJ; Choi IH; Han HM; Kim TH; Lee SH
    J Allergy Clin Immunol; 2019 Dec; 144(6):1551-1565.e2. PubMed ID: 31449915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive and effector B-cell subtypes are increased in chronic rhinosinusitis with polyps.
    Miljkovic D; Psaltis A; Wormald PJ; Vreugde S
    Am J Rhinol Allergy; 2018 Jan; 32(1):3-6. PubMed ID: 29336281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps.
    Kato A; Peters A; Suh L; Carter R; Harris KE; Chandra R; Conley D; Grammer LC; Kern R; Schleimer RP
    J Allergy Clin Immunol; 2008 Jun; 121(6):1385-92, 1392.e1-2. PubMed ID: 18410958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis.
    Seshadri S; Lin DC; Rosati M; Carter RG; Norton JE; Suh L; Kato A; Chandra RK; Harris KE; Chu HW; Peters AT; Tan BK; Conley DB; Grammer LC; Kern RC; Schleimer RP
    Allergy; 2012 Jul; 67(7):920-8. PubMed ID: 22676062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.